FDAnews Device Daily Bulletin

Implantable Device Reduces Seizures in Epileptic Patients

Feb. 19, 2013
A medical device company recently received funding from a branch of the NIH to conduct a new two-phase clinical trial for an internally-implanted electronic device that may help treat epilepsy. NeuroSigma, the company behind the device, is basing the new trial on evidence of a similar device, an electronic patch that has been shown to reduce symptoms of depression by up to 50 percent.